2018 BSR指南：炎性关节炎生物DMARD安全性
发布日期：
2018-08-21
英文标题：
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis.
出处：
Rheumatology (Oxford). 2018 Aug 21.
摘要：
生物治疗的应用改变了炎性关节炎的管理，该指南替代先前BSR/BHPR抗TNF，利妥昔单抗以及托珠单抗指南。主要目的是为＞18岁成人应用生物治疗提供循证建议。
展开部分内容仅可在
临床指南app 查看下载
收藏
分享
评论
提交评论
/ 没有更多了 /
上传者信息
wzy8982
于2018-08-27上传
编者信息
英国风湿病学会
BSR promotes excellence in the treatment of people with arthritis and musculoskeletal conditions and supports those delivering it. We have over 25 years of expertise in promoting high quality standards of care, providing education, training and support to those working in rheumatology. We have more than 1,500 members including rheumatologists, scientists, trainees, allied health professionals and others from the UK and overseas.
置顶
